Baylen C A , Rosenberg H (2006) A review of the acute subjective effects of MDMA/ecstasy . Addiction101: 933-947
2.
Brookhuis K A , de Waard D , Samyn N (2004) Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety . Psychopharmacology173: 440-445
3.
Cohen R S (1998). The Love Drug: Marching to the Beat of Ecstasy. Haworth Medical Press, New York
4.
Connor T J (2004) Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system . Immunology111: 357-367
5.
Cottler L B , Womack S B , Compton W M , Ben-Abdallah A (2001) Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria . Hum Psychopharmacol16: 599-606
6.
Cox W M (2006) Commentary on ‘Alcohol alternatives: a goal for psychopharmacology’ by David J. Nutt . J Psychopharmacol20: 327-328
7.
Curran H V , Rees H , Hoare T , Hoshi R , Bond A (2004) Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users . Psychopharmacology173: 425-433
8.
Easton N , Marsden C A (2006) Ecstasy: are animal data consistent between species and can they translate to humans?J Psychopharmacol20: 194-210
9.
Fox H C , Mclean A , Turner J J D , Parrott A C , Rogers R , Sahakian B J (2002) Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (ecstasy) polydrug users . Psychopharmacology162: 203-214
10.
Gerra G , Zaimovic A , Ampollini R , Giusti F , Delsignore R , Raggi M A , Laviola G , Macchia T , Brambilla F (2001) Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxymethamphetamine (‘Ecstasy’) use history: psychobiological correlates . J Subst Abuse13: 471-491
11.
Gesi M , Soldani P , Lenzi P , Ferrucci M , Giusiani A , Fornai F , Paparelli A (2002) Ecstasy during loud noise exposure induces dramatic ultrastructural changes in the heart . Pharmacol Toxicol91: 29-33
12.
Green A R , Mechan A O , Elliott J M , O’Shea E , Colado M I (2003) The pharmacology and clinical pharmacology of 3,4-methylene-dioxymethamphetamine (MDMA, ‘ecstasy’) . Pharmacol Revs55: 463-508
13.
Hoshi R , Pratt H , Mehta S , Bond A J , Curran H V (2006) An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood -are there gender differences?J Psychopharmacol20: 291-301
14.
Lock J , Thome J , Kissling C , Parrott A C (2006) Hormonal, temperature and mood changes in recreational Ecstasy/MDMA users out clubbing: a brief prospective study . Jour Psychopharmacol20: a52-a52
15.
Logan B K , Couper F J. (2001) 3,4- Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment . J Forensic Sci46: 1426-1433
16.
Maurer H H , Kraemer T , Springer D , Staack R F (2004) Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrolidinophenone types: a synopsis . Ther Drug Monit26: 127-131
17.
Milani R M , Parrott A C (2004) Psychological problems may be associated with Ecstasy dependence rather than Ecstasy lifetime dose . World J Biol Psychiat5: 130-134
18.
Montiel-Duarte C , Varela-Rey M , Oses-Prieto J A , Lopez-Zabalza M J , Beitia G , Cenarruzabeitia E , Iraburu M J (2002) 3,4- Methylene-dioxymethamphetamine (‘Ecstasy’) induces apoptosis of cultured rat liver cells . Biochim Biophys Acta1588: 26-32
19.
Navarro J F , Maldonado E (1999). Behavioral profile of 3,4-methylene-dioxymethamphetamine (MDMA) in agonistic encounters between male mice . Prog Neuropsychopharmacol Biol Psychiatry23: 327-334
20.
Nutt D J (2006). A tale of two Es . J Psychopharmacol20: 315-317
21.
Pacifici R , Zuccaro P , Farre M , Pichini S , Di Carlo S , Roset P N , Palmi I , Ortuno J , Menoyo E , Segura J , de la Torre R (2002) Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus non-controlled settings . Ann N Y Acad Sci965: 421-433 .
22.
Parrott A C (2001) Human psychopharmacology of Ecstasy (MDMA): a review of fifteen years of empirical research . Hum Psychopharmacol16: 557-577
23.
Parrott A C (2003) Cigarette-derived nicotine is not a medicine . World J Biol Psychiatry4: 49-55
24.
Parrott A C (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy . J Psychopharmacol19: 71-83
25.
Parrott A C (2006a) MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress . J Psychopharmacol20: 147-163
26.
Parrott A C (2006b) Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research . Psychopharmacology184: 567-576
27.
Parrott A C , Marsden C A (2006). MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective . J Psychopharmacol20: 143-146
28.
Parrott A C , Milani R , Parmar R , Turner J J D (2001) Ecstasy polydrug users and other recreational drug users in Britain and Italy: psychiatric symptoms and psychobiological problems . Psychopharmacology159: 77-82
29.
Parrott A C , Rodgers J , Buchanan T , Ling J , Heffernan T , Scholey A B (2006) Dancing hot on Ecstasy: physical exercise and feeling hot are associated with the neuropsychological problems reported by recreational MDMA users . Hum Psychopharmacol21: 285-298
30.
Reay J L , Hamilton C , Kennedy D , Scholey A B (2006) MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes . J Psychopharmacol20: 385-388
31.
Reneman L , de Win M M , van den Brink W , Booij J , den Heeten G J (2006). Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects . J Psychopharmacol20: 164-175
32.
Schifano F , Corkery J , Deluca P , Oyefeso A , Ghodse A H (2006). Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003) . J Psychopharmacol20: 456-463
33.
Setola V , Hufeisen S J , Grande-Allen K J , Vesely I , Glennon R A , Blough B , Rothman R B , Roth B L (2003) 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro . Mol Pharmacol63: 1223-1229
34.
Smith I D , Simpson K J , Garden O J , Wigmore S J (2005) Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland . Eur J Gastroenterol Hepatol17: 161-167
35.
Thomasius R , Zapletalova P , Petersen K , Buchert R , Andresen B , Wart-berg L , Nebeling B , Schmoldt A (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective . J Psychopharmacol20: 211-225
36.
English translation by: Pevear R, Volokhonsky L (2003). Allan Lane Penguin Books, London
37.
Topp L , Hando J , Dillon P , Roche A , Solowij N (1999). Ecstasy use in Australia: patterns of use and associated harm . Drug Alc Depend55: 105-115
38.
Zakzanis K K , Campbell Z (2006) Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up . Neurology66: 740-741
39.
Zhou J F , Chen P , Zhou Y H , Zhang L , Chen H H (2003) 3,4-methylenedioxymethamphetamine abuse may cause oxidative stress and potential free radical damage . Free radical Res37: 491-497
